Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

Also called NCT02013193

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
Hemoteq AG (from the registry)
Registry
  • NCT NCT02013193
Other papers using this trial's data
  • Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2017-08 DOI, PubMed 28558502

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, France, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02013193. Randomized; single masking; primary purpose treatment. Start 2014-01-07 (actual); primary completion 2016-06-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries
Acronym
RANGER-SFA
Condition
Peripheral Artery Disease
Condition
Claudication
Condition
Atherosclerosis
Condition
Arteriosclerosis
Intervention (Device)
Ranger DCB
Intervention (Device)
uncoated PTA balloon
Lead sponsor
Hemoteq AG (class: industry)
Collaborator
CERES GmbH (class: industry)
Collaborator
coreLab Black Forest GmbH (class: not stated)

Record details

Record id
cardio:ct-nct02013193
Content hash
d6cfa930191f5b0501512d38f1defa3cd93b610af972a5d4c40bf75e8a157635